Coated Plungers for Large Volume Biologics
Datwyler has launched new coated plungers in its NeoFlex line that are suitable for large volume biologics.
Datwyler NeoFlex Plungers for large volume biologics | © Datwyler
Datwyler’s newly launched coated plungers in the NeoFlex line come in sizes fit for containers aimed at large-volume auto-injectors and wearable devices. The new prefilled syringe 10 mL with its NeoFlex Cartridge Wearable 10 mL is designed for high quality and safety standards with the new plungers, which ensure the stability and safety of large-molecule drugs. These plungers are completely covered in a non-fluorosurfactant grade fluoropolymer coating, which prevents rubber particles from shedding and minimizes degradation from extractables and leachables. The plungers are inherently lubricious, which eliminates the need for silicone to ensure smooth operation inside the syringe or cartridge barrels. This characteristic also supports compatibility with complex formulations, which is especially crucial for the effective delivery of a highly sensitive, highly viscous biologic.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
